Howard P Goodkin
Overview
Explore the profile of Howard P Goodkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
1520
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ostendorf A, Loddenkemper T, Morgan L, Appavu B, Farias-Moeller R, Harrar D, et al.
Contemp Clin Trials
. 2025 Feb;
151:107831.
PMID: 39929261
Background: Acute seizures may evolve into status epilepticus (SE), prolonged and self-sustaining seizures that may result in brain injury or death. Rapid treatment with a benzodiazepine (BZD) is most effective....
2.
Gettings J, Chafjiri F, Patel A, Shorvon S, Goodkin H, Loddenkemper T
Lancet Neurol
. 2024 Dec;
24(1):65-76.
PMID: 39637874
Status epilepticus is a common neurological emergency that is characterised by prolonged or recurrent seizures without recovery between episodes and associated with substantial morbidity and mortality. Prompt recognition and targeted...
3.
Barcia Aguilar C, Amengual-Gual M, Brenton J, Chapman K, Clark J, Gaillard W, et al.
Seizure
. 2024 Nov;
123:133-141.
PMID: 39550933
Purpose: Evaluate the relationship between first and second-line medication dosing and progression to refractory status epilepticus (RSE) in children. Methods: This is a retrospective analysis of prospectively collected data from...
4.
Quigg M, Bonnie R, Bauer D, Goodkin H, Kapur J
Epilepsy Res
. 2024 Jul;
205:107398.
PMID: 38976952
Detailed descriptions of violent postictal episodes are rare. We provide evidence from an index case and from a systematic review of violent postictal episodes that demonstrates the encephalopathic features of...
5.
Hartnett P, Zomorodi N, Goodkin H, Zawar I
Epilepsia Open
. 2024 Jun;
9(4):1604-1610.
PMID: 38923414
Due to extensive connectivity of the parietal lobe, non-lesional drug-resistant (DRE) parietal lobe epilepsies (PLEs) are difficult to localize and often imitate other epilepsies. Therefore, patients with PLEs have low...
6.
Jeffries L, Mis E, McWalter K, Donkervoort S, Brodsky N, Carpier J, et al.
Genet Med
. 2023 Nov;
26(2):101023.
PMID: 37947183
Purpose: We sought to delineate a multisystem disorder caused by recessive cysteine-rich with epidermal growth factor-like domains 1 (CRELD1) gene variants. Methods: The impact of CRELD1 variants was characterized through...
7.
Amengual-Gual M, Sanchez Fernandez I, Vasquez A, Abend N, Anderson A, Arya R, et al.
Seizure
. 2023 Jul;
111:51-55.
PMID: 37523933
Purpose: Delayed treatment in status epilepticus (SE) is independently associated with increased treatment resistance, morbidity, and mortality. We describe the prehospital management pathway and Emergency Medical Services (EMS) timeliness in...
8.
Morgan L, Hrachovec J, Goodkin H
Paediatr Drugs
. 2023 May;
25(4):411-424.
PMID: 37178271
Pediatric convulsive status epilepticus (cSE) is a neurologic emergency with potential for morbidity and mortality. Rapid treatment and escalation of therapies to achieve early seizure control is paramount in preventing...
9.
Patel M, Middleton J, Goodkin H, Barnes B, McGowan E, Eid R
JPGN Rep
. 2023 May;
3(4):e253.
PMID: 37168471
Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with varying side effects, ranging from somnolence to diarrhea and weight loss. We present a patient on...
10.
Rundfeldt C, Klein P, Boison D, Rotenberg A, DAmbrosio R, Eastman C, et al.
Epilepsia
. 2023 Jan;
64(4):888-899.
PMID: 36708090
Objective: For an antiseizure medication (ASM) to be effective in status epilepticus (SE), the drug should be administered intravenously (i.v.) to provide quick access to the brain. However, poor aqueous...